47 results
8-K
PCSA
Processa Pharmaceuticals Inc
12 Oct 17
Entry into a Material Definitive Agreement
12:00am
to be manufactured in commercial quantities or at an acceptable cost;
physicians may not receive any reimbursement from third-party payors … , or the level of reimbursement may be insufficient to support widespread adoption of any of our future products; and
rapid technological change may make our
8-K
vac52 sag
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
egyr0uo8 m7jucf
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-10.1
ogxh vhm2z8ktc
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
424B5
0yo26il
20 Aug 21
Prospectus supplement for primary offering
4:46pm